158 related articles for article (PubMed ID: 35883114)
1. Pregnancy rates and outcomes in a longitudinal HIV cohort in the context of evolving antiretroviral treatment provision in South Africa.
Naicker N; Yende-Zuma N; Kharsany ABM; Shozi H; Nkosi D; Naidoo A; Garrett N; Abdool Karim SS
BMC Pregnancy Childbirth; 2022 Jul; 22(1):596. PubMed ID: 35883114
[TBL] [Abstract][Full Text] [Related]
2. The next generation: Pregnancy in adolescents and women living with perinatally acquired HIV in South Africa.
Anderson K; Mutemaringa T; Technau KG; Johnson LF; Braithwaite K; Mokotoane E; Boulle A; Davies On Behalf Of IeDEA-Sa Pediatrics MA
S Afr Med J; 2021 Mar; 111(3):260-264. PubMed ID: 33944749
[TBL] [Abstract][Full Text] [Related]
3. Plasma viraemia in HIV-positive pregnant women entering antenatal care in South Africa.
Myer L; Phillips TK; Hsiao NY; Zerbe A; Petro G; Bekker LG; McIntyre JA; Abrams EJ
J Int AIDS Soc; 2015; 18(1):20045. PubMed ID: 26154734
[TBL] [Abstract][Full Text] [Related]
4. Pregnancy and infant outcomes among HIV-infected women taking long-term ART with and without tenofovir in the DART trial.
Gibb DM; Kizito H; Russell EC; Chidziva E; Zalwango E; Nalumenya R; Spyer M; Tumukunde D; Nathoo K; Munderi P; Kyomugisha H; Hakim J; Grosskurth H; Gilks CF; Walker AS; Musoke P;
PLoS Med; 2012; 9(5):e1001217. PubMed ID: 22615543
[TBL] [Abstract][Full Text] [Related]
5. Factors associated with vertical transmission of HIV in the Western Cape, South Africa: a retrospective cohort analysis.
Anderson K; Kalk E; Heekes A; Phelanyane F; Jacob N; Boulle A; Mehta U; Kassanjee R; Sridhar G; Ragone L; Vannappagari V; Davies MA
J Int AIDS Soc; 2024 Mar; 27(3):e26235. PubMed ID: 38528395
[TBL] [Abstract][Full Text] [Related]
6. HIV viraemia and mother-to-child transmission risk after antiretroviral therapy initiation in pregnancy in Cape Town, South Africa.
Myer L; Phillips TK; McIntyre JA; Hsiao NY; Petro G; Zerbe A; Ramjith J; Bekker LG; Abrams EJ
HIV Med; 2017 Feb; 18(2):80-88. PubMed ID: 27353189
[TBL] [Abstract][Full Text] [Related]
7. Short-term antiretroviral therapy to prevent mother-to-child transmission is safe and results in a sustained increase in CD4 T-cell counts in HIV-1-infected mothers.
Palacios R; Senise J; Vaz M; Diaz R; Castelo A
HIV Med; 2009 Mar; 10(3):157-62. PubMed ID: 19245537
[TBL] [Abstract][Full Text] [Related]
8. Mother-to-child transmission of HIV in a community-based antiretroviral clinic in South Africa.
Fitzgerald FC; Bekker LG; Kaplan R; Myer L; Lawn SD; Wood R
S Afr Med J; 2010 Dec; 100(12):827-31. PubMed ID: 21414276
[TBL] [Abstract][Full Text] [Related]
9. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
Sturt AS; Dokubo EK; Sint TT
Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
[TBL] [Abstract][Full Text] [Related]
10. Population-level risk factors for vertical transmission of HIV in the national prevention of mother-to-child transmission programme in South Africa: An ecological analysis.
Moyo F; Haeri Mazanderani A; Sherman GG; Kufa T
S Afr Med J; 2022 Mar; 112(3):219-226. PubMed ID: 35380525
[TBL] [Abstract][Full Text] [Related]
11. Low Pretreatment Viral Loads in Infants With HIV in an Era of High-maternal Antiretroviral Therapy Coverage.
Patel F; Shiau S; Strehlau R; Shen Y; Burke M; Paximadis M; Shalekoff S; Schramm D; Technau KG; Sherman GG; Coovadia A; Tiemessen CT; Abrams EJ; Kuhn L
Pediatr Infect Dis J; 2021 Jan; 40(1):55-59. PubMed ID: 32925542
[TBL] [Abstract][Full Text] [Related]
12. Mother-to-child transmission of HIV: experience at a referral hospital in Saudi Arabia.
Edathodu J; Halim MM; Dahham MB; Alrajhi AA
Ann Saudi Med; 2010; 30(1):15-7. PubMed ID: 20103953
[TBL] [Abstract][Full Text] [Related]
13. Infectious morbidity of breastfed, HIV-exposed uninfected infants under conditions of universal antiretroviral therapy in South Africa: a prospective cohort study.
le Roux SM; Abrams EJ; Donald KA; Brittain K; Phillips TK; Zerbe A; le Roux DM; Kroon M; Myer L
Lancet Child Adolesc Health; 2020 Mar; 4(3):220-231. PubMed ID: 31932246
[TBL] [Abstract][Full Text] [Related]
14. Same-day antiretroviral therapy (ART) initiation in pregnancy is not associated with viral suppression or engagement in care: A cohort study.
Langwenya N; Phillips TK; Brittain K; Zerbe A; Abrams EJ; Myer L
J Int AIDS Soc; 2018 Jun; 21(6):e25133. PubMed ID: 29939483
[TBL] [Abstract][Full Text] [Related]
15. [Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)].
Panel de expertos de Gesida y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2012 Jun; 30(6):e1-89. PubMed ID: 22633764
[TBL] [Abstract][Full Text] [Related]
16. Effect of Pregnancy on Response to Antiretroviral Therapy in HIV-Infected African Women.
Kourtis AP; Wiener J; King CC; Heffron R; Mugo NR; Nanda K; Pyra M; Donnell D; Celum C; Lingappa JR; Baeten JM;
J Acquir Immune Defic Syndr; 2017 Jan; 74(1):38-43. PubMed ID: 27787340
[TBL] [Abstract][Full Text] [Related]
17. Management of human immunodeficiency virus-infected pregnant women at Latin American and Caribbean sites.
Read JS; Cahn P; Losso M; Pinto J; Joao E; Duarte G; Cardoso E; Freimanis-Hance L; Stoszek SK;
Obstet Gynecol; 2007 Jun; 109(6):1358-67. PubMed ID: 17540808
[TBL] [Abstract][Full Text] [Related]
18. Timing of pregnancy, postpartum risk of virologic failure and loss to follow-up among HIV-positive women.
Onoya D; Sineke T; Brennan AT; Long L; Fox MP
AIDS; 2017 Jul; 31(11):1593-1602. PubMed ID: 28463877
[TBL] [Abstract][Full Text] [Related]
19. Adherence to HIV antiretroviral therapy among pregnant and postpartum women during the Option B+ era: 12-month cohort study in urban South Africa and rural Uganda.
Matthews LT; Orrell C; Bwana MB; Tsai AC; Psaros C; Asiimwe S; Amanyire G; Musinguzi N; Bell K; Bangsberg DR; Haberer JE;
J Int AIDS Soc; 2020 Aug; 23(8):e25586. PubMed ID: 32820622
[TBL] [Abstract][Full Text] [Related]
20. Getting pregnant in HIV clinical trials: women's choice and safety needs. The experience from the ANRS12169-2LADY and ANRS12286-MOBIDIP trials.
Serris A; Zoungrana J; Diallo M; Toby R; Mpoudi Ngolle M; Le Gac S; Coutherut J; Cournil A; De Beaudrap P; Koulla-Shiro S; Delaporte E; Ciaffi L
HIV Clin Trials; 2016 Nov; 17(6):233-241. PubMed ID: 27801628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
